相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Steroid-Resistant Kaposiform Hemangioendothelioma: A Retrospective Study of 37 Patients Treated With Vincristine and Long-Term Follow-up
Zuopeng Wang et al.
PEDIATRIC BLOOD & CANCER (2015)
The novel AKT inhibitor afuresertib shows favorable safety, pharmacokinetics, and clinical activity in multiple myeloma
Andrew Spencer et al.
BLOOD (2014)
Clinical analysis of kasabach-merritt syndrome in 17 neonates
Ping Wang et al.
BMC PEDIATRICS (2014)
A parallel-arm phase I trial of the humanised anti-IGF-1R antibody dalotuzumab in combination with the AKT inhibitor MK-2206, the mTOR inhibitor ridaforolimus, or the NOTCH inhibitor MK-0752, in patients with advanced solid tumours
I. Brana et al.
BRITISH JOURNAL OF CANCER (2014)
Kasabach-Merritt phenomenon in an adult man with a tufted angioma and cirrhosis responding to radiation, bevacizumab, and prednisone
Anthony P. Fernandez et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2014)
Sirolimus, a promising treatment for refractory Kaposiform hemangioendothelioma
Li Kai et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2014)
Laryngomalacia and Complicated, Life-threatening mTOR-positive Kaposiform Hemangioendothelioma Cured by Supraglottoplasty and Sirolimus
U. Schroeder et al.
KLINISCHE PADIATRIE (2014)
Multicenter Randomized Phase 2 Clinical Trial of a Recombinant Human Endostatin Adenovirus in Patients with Advanced Head and Neck Carcinoma
Wen Ye et al.
MOLECULAR THERAPY (2014)
Variable response to propranolol treatment of kaposiform hemangioendothelioma, tufted angioma, and Kasabach-Merritt phenomenon
Zuopeng Wang et al.
PEDIATRIC BLOOD & CANCER (2014)
Late-Onset Tufted Angioma with Remarkable Response to Pulse Dye Laser
Reza M. Robati et al.
INDIAN JOURNAL OF DERMATOLOGY (2014)
Neoadjuvant rh-endostatin, docetaxel and epirubicin for breast cancer: efficacy and safety in a prospective, randomized, phase II study
Jianghao Chen et al.
BMC CANCER (2013)
Effect of Thalidomide on Clinical Remission in Children and Adolescents With Refractory Crohn Disease A Randomized Clinical Trial
Marzia Lazzerini et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
Bevacizumab-Associated Osteonecrosis of the Wrist and Knee in Three Pediatric Patients With Recurrent CNS Tumors
Jason Fangusaro et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Kasabach-Merritt Phenomenon: A Report of 11 Cases From a Single Institution
Naoko Yasui et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2013)
Kaposiform Hemangioendothelioma: Atypical Features and Risks of Kasabach-Merritt Phenomenon in 107 Referrals
Stacy E. Croteau et al.
JOURNAL OF PEDIATRICS (2013)
Consensus-Derived Practice Standards Plan for Complicated Kaposiform Hemangioendothelioma
Beth A. Drolet et al.
JOURNAL OF PEDIATRICS (2013)
A Phase II, Randomized, Double-blind, Placebo-controlled Multicenter Trial of Endostar in Patients With Metastatic Melanoma
Chuanliang Cui et al.
MOLECULAR THERAPY (2013)
Long-term outcome of vincristine-aspirin-ticlopidine (VAT) therapy for vascular tumors associated with kasabach-merritt phenomenon
Israel Fernandez-Pineda et al.
PEDIATRIC BLOOD & CANCER (2013)
Infantile Hemangiomas: An Update on Pathogenesis and Therapy
Tina S. Chen et al.
PEDIATRICS (2013)
Rapidly Enlarging Bruise on the Back of an Infant
Stephanie Chan et al.
JAMA DERMATOLOGY (2013)
Sirolimus (Rapamycin) in patients with Kaposiform hemangioendothelioma. Clinical case
Natalie Rodriguez Z et al.
REVISTA CHILENA DE PEDIATRIA-CHILE (2013)
Dilated Lymphatic Vessels in Tufted Angioma: A Potential Source of Diagnostic Confusion
Mona Sadeghpour et al.
AMERICAN JOURNAL OF DERMATOPATHOLOGY (2012)
Kaposiform Hemangioendothelioma with Kasabach-Merritt phenomenon: Successful Treatment with Vincristine and Ticlopidine
Roman Barabash-Neila et al.
INDIAN JOURNAL OF PEDIATRICS (2012)
Bevacizumab in Patients With Hereditary Hemorrhagic Telangiectasia and Severe Hepatic Vascular Malformations and High Cardiac Output
Sophie Dupuis-Girod et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
Endoscopic Management of Gastrointestinal Bleeding From Multifocal Lymphangioendotheliomatosis With Thrombocytopenia: Limited Efficacy and Complications
Richard J. Noel et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2012)
Kaposiform Hemangioendothelioma with Kasabach-Merritt Phenomenon: From Vincristine to Sirolimus
J. Jahnel et al.
KLINISCHE PADIATRIE (2012)
Variable response to propranolol treatment of kaposiform hemangioendothelioma, tufted angioma, and Kasabach-Merritt phenomenon
Yvonne E. Chiu et al.
PEDIATRIC BLOOD & CANCER (2012)
Vincristine, actinomycin D, cyclophosphamide chemotherapy resolves Kasabach-Merritt syndrome resistant to conventional therapies
Yasushi Fuchimoto et al.
PEDIATRICS INTERNATIONAL (2012)
Release of angiogenesis regulatory proteins from platelet alpha granules: modulation of physiologic and pathologic angiogenesis
Elisabeth M. Battinelli et al.
BLOOD (2011)
Vincristine-resistant Kasabach-Merritt phenomenon successfully treated with low-dose radiotherapy
Yuko Watanabe et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2011)
First-in-Man Clinical Trial of the Oral Pan-AKT Inhibitor MK-2206 in Patients With Advanced Solid Tumors
Timothy A. Yap et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Kaposiform Hemangioendothelioma With Kasabach-Merritt Syndrome: A New Indication for Propranolol Treatment
Denise Josephina Johanna Hermans et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2011)
Sirolimus for the Treatment of Complicated Vascular Anomalies in Children
Adrienne M. Hammill et al.
PEDIATRIC BLOOD & CANCER (2011)
Clinical Spectrum of Tufted Angiomas in Childhood
Amélie Osio et al.
ARCHIVES OF DERMATOLOGY (2010)
Novel function for blood platelets and podoplanin in developmental separation of blood and lymphatic circulation
Pavel Uhrin et al.
BLOOD (2010)
Kasabach-Merritt phenomenon: a single centre experience
Clodagh Ryan et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2010)
Successful Treatment of Kaposiform Hemangioendothelioma and Tufted Angioma With Vincristine
Farzan Fahrtash et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2010)
Treatment of Childhood Kaposiform Hemangioendothelioma With Sirolimus
Julie Blatt et al.
PEDIATRIC BLOOD & CANCER (2010)
Platelets actively sequester angiogenesis regulators
Giannoula Lakka Klement et al.
BLOOD (2009)
Guidelines for the diagnosis and management of disseminated intravascular coagulation
M. Levi et al.
BRITISH JOURNAL OF HAEMATOLOGY (2009)
Case Report: Kaposiform Hemangioendothelioma in Multiple Spinal Levels Without Skin Changes
Jennifer W. Lisle et al.
CLINICAL ORTHOPAEDICS AND RELATED RESEARCH (2009)
Use of radiotherapy to treat life-threatening Kasabach-Merritt syndrome
E. Leong et al.
JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY (2009)
Refractory Kaposiform Hemangioendothelioma That Expressed Vascular Endothelial Growth Factor Receptor (VEGFR)-2 and VEGFR-3 A Case Report
Mari Saito et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2009)
Bevacizumab Treatment in Multifocal Lymphangioendotheliomatosis With Thrombocytopenia
Ronald M. Kline et al.
PEDIATRIC BLOOD & CANCER (2009)
Mediastinal and Neck Kaposiform Hemangioendothelioma: Report of Three Cases
Grainne M. O'Regan et al.
PEDIATRIC DERMATOLOGY (2009)
Association of localized intravascular coagulopathy with venous malformations
Anne Dompmartin et al.
ARCHIVES OF DERMATOLOGY (2008)
Phase I trial and pharmacokinetic study of bevacizumab in pediatric patients with refractory solid tumors: A children's oncology group study
Julia L. Glade Bender et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Reversible skeletal changes after treatment with bevacizumab in a child with cutaneovisceral angiomatosis with thrombocytopenia syndrome
Angela R. Smith et al.
PEDIATRIC BLOOD & CANCER (2008)
Angiogenesis is regulated by a novel mechanism:: pro- and antiangiogenic proteins are organized into separate platelet α granules and differentially released
Joseph E. Italiano et al.
BLOOD (2008)
Hypoxia-induced mediators of stem/progenitor cell trafficking are increased in children with hemangioma
Mark E. Kleinman et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
Involvement of the snake toxin receptor CLEC-2, in podoplanin-mediated platelet activation, by cancer cells
Katsue Suzuki-Inoue et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Haemangiomas and vascular malformations of the limb in children
Mairi Steven et al.
PEDIATRIC SURGERY INTERNATIONAL (2007)
Truncal location of hemangioendotheliomas may indicate potentially more serious involvement with resulting Kasabach-Merritt syndrome than size determinant alone
PR Carrington
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2006)
Recombinant human angiostatin (rhAngiostatin) in combination with paclitaxel and carboplatin in patients with advanced non-small-cell lung cancer: a phase II study from Indiana University
A Kurup et al.
ANNALS OF ONCOLOGY (2006)
D2-40 immunohistochemical analysis of pediatric vascular tumors reveals positivity in kaposiform hemangioendothelioma
LV Debelenko et al.
MODERN PATHOLOGY (2005)
Kaposiform hemangioendothelioma without Kasabach-Merritt phenomenon
A Gruman et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2005)
Spastic diplegia and other motor disturbances in infants receiving interferon-alpha
AP Michaud et al.
LARYNGOSCOPE (2004)
Treatment of Kasabach-Merritt syndrome: a stepwise regimen of prednisolone, dipyridamole, and interferon
S Wananukul et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2003)
The biology of VEGF and its receptors
N Ferrara et al.
NATURE MEDICINE (2003)
Response of childhood tufted angioma to the pulsed-dye laser
R Mahendran et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2002)
Kasabach-Merritt phenomenon: A retrospective study of treatment with vincristine
C Haisley-Royster et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2002)
Early surgical intervention in a patient with Kasabach-Merritt phenomenon
BA Drolet et al.
JOURNAL OF PEDIATRICS (2001)
Stepwise multimodal approach in the treatment of Kasabach-Merritt syndrome
HY Shin et al.
PEDIATRICS INTERNATIONAL (2000)
Cervicofacial angioma and the Kasabach-Merritt syndrome
G Bornet et al.
NEURORADIOLOGY (2000)
Vascular endothelial growth factor receptor-3 (VEGFR-3): A marker of vascular tumors with presumed lymphatic differentiation, including Kaposi's sarcoma, kaposiform and Dabska-type hemangioendotheliomas, and a subset of angiosarcomas
AL Folpe et al.
MODERN PATHOLOGY (2000)
Residual lesions after Kasabach-Merritt phenomenon in 41 patients
O Enjolras et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2000)
分享论文
